298 related articles for article (PubMed ID: 14662739)
1. IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients.
Erbay E; Park IH; Nuzzi PD; Schoenherr CJ; Chen J
J Cell Biol; 2003 Dec; 163(5):931-6. PubMed ID: 14662739
[TBL] [Abstract][Full Text] [Related]
2. Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis.
Yoon MS; Chen J
Mol Biol Cell; 2013 Dec; 24(23):3754-63. PubMed ID: 24068326
[TBL] [Abstract][Full Text] [Related]
3. Role of phosphatidylinositol 3,4,5-trisphosphate (PIP3) 5-phosphatase skeletal muscle- and kidney-enriched inositol polyphosphate phosphatase (SKIP) in myoblast differentiation.
Ijuin T; Takenawa T
J Biol Chem; 2012 Sep; 287(37):31330-41. PubMed ID: 22815484
[TBL] [Abstract][Full Text] [Related]
4. Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components.
Wu AL; Kim JH; Zhang C; Unterman TG; Chen J
Endocrinology; 2008 Mar; 149(3):1407-14. PubMed ID: 18079193
[TBL] [Abstract][Full Text] [Related]
5. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.
Wilson EM; Tureckova J; Rotwein P
Mol Biol Cell; 2004 Feb; 15(2):497-505. PubMed ID: 14595115
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
8. IGF-II-mediated downregulation of peroxisome proliferator-activated receptor-γ coactivator-1α in myoblast cells involves PI3K/Akt/FoxO1 signaling pathway.
Mu X; Qi W; Liu Y; Zhou J; Li Y; Rong X; Lu L
Mol Cell Biochem; 2017 Aug; 432(1-2):199-208. PubMed ID: 28374141
[TBL] [Abstract][Full Text] [Related]
9. IGF-II is regulated by microRNA-125b in skeletal myogenesis.
Ge Y; Sun Y; Chen J
J Cell Biol; 2011 Jan; 192(1):69-81. PubMed ID: 21200031
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of IGF-I and IGF-II gene expression in skeletal muscle cells.
Jiao S; Ren H; Li Y; Zhou J; Duan C; Lu L
Mol Cell Biochem; 2013 Jan; 373(1-2):107-13. PubMed ID: 23054195
[TBL] [Abstract][Full Text] [Related]
11. Progranulin compensates for blocked IGF-1 signaling to promote myotube hypertrophy in C2C12 myoblasts via the PI3K/Akt/mTOR pathway.
Hu SY; Tai CC; Li YH; Wu JL
FEBS Lett; 2012 Sep; 586(19):3485-92. PubMed ID: 22967900
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation.
Song YH; Godard M; Li Y; Richmond SR; Rosenthal N; Delafontaine P
J Investig Med; 2005 Apr; 53(3):135-42. PubMed ID: 15921033
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.
Ma M; Wang X; Chen X; Cai R; Chen F; Dong W; Yang G; Pang W
RNA Biol; 2017 Mar; 14(3):347-360. PubMed ID: 28085550
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia converts the myogenic action of insulin-like growth factors into mitogenic action by differentially regulating multiple signaling pathways.
Ren H; Accili D; Duan C
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5857-62. PubMed ID: 20231451
[TBL] [Abstract][Full Text] [Related]
15. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
[TBL] [Abstract][Full Text] [Related]
16. Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism.
Hornberger TA; Stuppard R; Conley KE; Fedele MJ; Fiorotto ML; Chin ER; Esser KA
Biochem J; 2004 Jun; 380(Pt 3):795-804. PubMed ID: 15030312
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-1 (IGF-1) promotes myoblast proliferation and skeletal muscle growth of embryonic chickens via the PI3K/Akt signalling pathway.
Yu M; Wang H; Xu Y; Yu D; Li D; Liu X; Du W
Cell Biol Int; 2015 Aug; 39(8):910-22. PubMed ID: 25808997
[TBL] [Abstract][Full Text] [Related]
18. Rab5a activates IRS1 to coordinate IGF-AKT-mTOR signaling and myoblast differentiation during muscle regeneration.
Cong XX; Gao XK; Rao XS; Wen J; Liu XC; Shi YP; He MY; Shen WL; Shen Y; Ouyang H; Hu P; Low BC; Meng ZX; Ke YH; Zheng MZ; Lu LR; Liang YH; Zheng LL; Zhou YT
Cell Death Differ; 2020 Aug; 27(8):2344-2362. PubMed ID: 32051546
[TBL] [Abstract][Full Text] [Related]
19. Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1).
Ge Y; Yoon MS; Chen J
J Biol Chem; 2011 Oct; 286(41):35675-35682. PubMed ID: 21852229
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2.
Matheny RW; Lynch CM; Leandry LA
Growth Factors; 2012 Dec; 30(6):367-84. PubMed ID: 23137199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
